Metraipolis › archive › dc_be41748dc297

Antihypertensive Treatment and Risk of Metabolic Associated Fatty Liver Disease: A Drug-Target Mendelian Randomization — Europe PMC PMID:42755691

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42755691
DOI
10.1161/hypertensionaha.126.27526
License (as archived)
solo-consultazione
Archived
2026-10-31T18:25:45.142Z
SHA-256 of the archived text
60276a1a743cd8fc688111e25497327f6e78482848db072316accec2a043507c
Stable URL of this page
https://metraipolis.com/documento/dc_be41748dc297

How to cite

Antihypertensive Treatment and Risk of Metabolic Associated Fatty Liver Disease: A Drug-Target Mendelian Randomization — Europe PMC PMID:42755691 — Europe PMC (en), https://europepmc.org/article/MED/42755691 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_be41748dc297 (Metraipolis archive dc_be41748dc297, sha256 60276a1a743cd8fc688111e25497327f6e78482848db072316accec2a043507c)
BibTeX
@misc{dcbe41748dc297,
  title = {Antihypertensive Treatment and Risk of Metabolic Associated Fatty Liver Disease: A Drug-Target Mendelian Randomization — Europe PMC PMID:42755691},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42755691},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_be41748dc297; sha256 60276a1a743cd8fc688111e25497327f6e78482848db072316accec2a043507c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42755691. Agents can read the archived copy with the MCP tool read_document.